Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Sep 9;23(2):2411-2414.
doi: 10.1007/s40200-024-01493-5. eCollection 2024 Dec.

A comment on: "Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide"

Mandana Hasanzad  1 , George P Patrinos  2   3   4 , Hamid Reza Aghaei Meybodi  5 , Shekoufeh Nikfar  1 , Bagher Larijani  6
Affiliations
Editorial

A comment on: "Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide"

Mandana Hasanzad et al. J Diabetes Metab Disord. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThere are no conflicts of interest declared by the authors.

Figures

Fig. 1
Fig. 1
This figure illustrates NAION as a multifactorial condition influenced by genetic predisposition and other risk factors. The central diagram represents NAION, influenced by genetic factors and environmental and pharmacological influences. The genetic factors section highlights variations implicated in NAION susceptibility, underscoring the role of precision medicine in identifying at-risk individuals. The environmental and pharmacological factors section shows potential triggers, such as medication use like semaglutide, that may interact with genetic predispositions
See this image and copyright information in PMC

References

    1. Hathaway JT, Shah MP, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW Jr et al. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in patients prescribed Semaglutide. JAMA Ophthalmol. 2024;142(8):732–739. - PMC - PubMed
    1. Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye (Lond). 2015;29(1):65–79. - PMC - PubMed
    1. Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol. 1985;103(8):1136–42. - PubMed
    1. Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and Cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221–32. - PubMed
    1. Liu B, Yu Y, Liu W, Deng T, Xiang D. Risk factors for non-arteritic Anterior Ischemic Optic Neuropathy: a large scale Meta-analysis. Front Med (Lausanne). 2021;8:618353. - PMC - PubMed

Publication types

LinkOut - more resources